Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lutemax 2020
- Development stage
- Unknown
- Lead developer
- OmniActive Health Technologies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Lutemax 2020 is a patented, naturally-derived dietary supplement ingredient produced from marigold flowers (*Tagetes erecta* L.) by OmniActive Health Technologies. It provides a specific 5:1 ratio of macular carotenoids, including lutein, RR-zeaxanthin, and RS (meso)-zeaxanthin. These carotenoids are deposited in the macula of the eye and in brain tissue, where they act as antioxidants and filter high-energy blue light. The ingredient is primarily used in nutritional supplements to support visual function, protect against age-related macular degeneration (AMD), and mitigate the effects of digital screen exposure. Clinical studies have also explored its benefits for cognitive health, sleep quality, and stress reduction.
- Brand names
- Lutemax 2020Lutemax2020Lutemax-2020
- Other names
- Marigold flower extractLutein and zeaxanthin isomers
02
Targets
GSTP1 (Glutathione S-transferase P)STARD4 (StAR-related lipid transfer domain-containing protein 3)
Beyond the preview
Go deeper on Lutemax 2020.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lutemax 2020.